Floatz logo

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE

Postpartum Depression

Grace Lim, MD, MSSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Postpartum Depression cohort.

Asset / SponsorPhaseRating
ALLOPREGNAN-3.ALPHA.-OL-20-ONE
Supernus Pharmaceuticals, Inc.
Phase 3BBB
Sertraline
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4BB
Zuranolone
Biogen
Phase 3BB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
Stanford University
Phase 4BB
Cipralex
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3BB

View all 12 →

Same molecule, other indications

(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE is also rated in:

major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →